(Q37744727)

22 August 2017

0 references

1 reference

title

Nucleoside reverse transcriptase inhibitors in combination therapy for HIV patients: systematic review and meta-analysis (English)

1 reference

22 August 2017

1 reference

1 reference

1

M Chowers

1 reference

22 August 2017

3

L Leibovici

1 reference

22 August 2017

B-S Gottesman

2

1 reference

22 August 2017

J M Schapiro

series ordinal

4

1 reference

22 August 2017

M Paul

series ordinal

5

1 reference

22 August 2017

language of work or name

1 reference

7 May 2010

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

22 August 2017

published in

1 reference

22 August 2017

volume

29

1 reference

22 August 2017

issue

7

1 reference

22 August 2017

page(s)

779-786

1 reference

https://scigraph.springernature.com/pub.10.1007/s10096-010-0926-y

22 August 2017

exact match

0 references

cites work

Antiviral activity of enteric-coated didanosine, stavudine, and nelfinavir versus zidovudine plus lamivudine and nelfinavir

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10096-010-0926-Y

Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection.

21 January 2018

1 reference

12 December 2020

Once-a-day therapy for HIV infection: a controlled, randomized study in antiretroviral-naive HIV-1-infected patients

1 reference

12 December 2020

An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults

1 reference

12 December 2020

A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II).

1 reference

12 December 2020

Improvement of the study, analysis, and reporting of adverse events associated with antiretroviral therapy

1 reference

12 December 2020

Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of HIV type 1 infection: final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903.

1 reference

12 December 2020

A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study

1 reference

12 December 2020

Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial

1 reference

12 December 2020

Measuring inconsistency in meta-analyses

1 reference

12 December 2020

Efficacy and tolerability of initial antiretroviral therapy: a systematic review

1 reference

12 December 2020

Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study

1 reference

12 December 2020

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

1 reference

12 December 2020

A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I).

1 reference

12 December 2020

Incidence of pancreatitis in HIV-infected patients, and the association with antiretroviral therapy

1 reference

12 December 2020

Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection.

1 reference

12 December 2020

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients

1 reference

12 December 2020

Efficacy and safety of emtricitabine vs stavudine in combination therapy in antiretroviral-naive patients: a randomized trial

1 reference

12 December 2020

Tenofovir disoproxil fumarate, emtricitabine, and efavirenz compared with zidovudine/lamivudine and efavirenz in treatment-naive patients: 144-week analysis

1 reference

12 December 2020

Randomized, open-label, comparative trial to evaluate the efficacy and safety of three antiretroviral drug combinations including two nucleoside analogues and nevirapine for previously untreated HIV-1 Infection: the OzCombo 2 study

1 reference

12 December 2020

A prospective, 96-week study of the impact of Trizivir, Combivir/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity

1 reference

12 December 2020

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

1 reference

12 December 2020

Incidence of acute pancreatitis and nucleoside reverse transcriptase inhibitors usage

1 reference

12 December 2020

European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults.

1 reference

12 December 2020

Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.

1 reference

12 December 2020

Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults

1 reference

12 December 2020

A randomized study comparing a three- and four-drug HAART regimen in first-line therapy (QUAD study).

1 reference

12 December 2020

Less lipoatrophy and better lipid profile with abacavir as compared to stavudine: 96-week results of a randomized study

1 reference

12 December 2020

Efficacy and safety of abacavir plus lamivudine versus didanosine plus stavudine when combined with a protease inhibitor, a nonnucleoside reverse transcriptase inhibitor, or both in HIV-1 positive antiretroviral-naive persons.

1 reference

12 December 2020

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

1 reference

12 December 2020

Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort

1 reference

12 December 2020

Acute pancreatitis associated with different combination therapies in patients infected with human immunodeficiency virus

1 reference

12 December 2020

10.1007/S10096-010-0926-Y

Identifiers

DOI

1 reference

22 August 2017

1 reference